A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2025 | $14.54 M | -66.31% |
2024 | $43.18 M | -16.96% |
2023 | $51.99 M | -66.55% |
2022 | $0.15 B | 200.46% |
2021 | $51.74 M | -9.83% |
2020 | $57.38 M | 52.34% |
2019 | $37.66 M | 46.52% |
2018 | $25.7 M | -70.97% |
2017 | $88.54 M | 191.96% |
2016 | $30.32 M | -14.94% |
2015 | $35.65 M | 68.07% |
2014 | $21.21 M | 152.1% |
2013 | $8.41 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Arrowhead Pharmaceuticals
ARWR | $0.65 M | $5.78 M | ๐บ๐ธ USA |
![]() Regeneron Pharmaceuticals REGN | $38.33 M | $74.85 M | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | $9.57 M | $43.17 M | ๐บ๐ธ USA |
![]() OPKO Health
OPK | $5.6 M | $23.25 M | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | $5.14 M | $7.59 M | ๐บ๐ธ USA |
![]() Novartis NVS | $41.23 M | $0.16 B | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $28.15 M | $43.66 M | ๐ซ๐ท France |
![]() Teva Pharmaceutical Industries TEVA | $12.09 M | $40.39 M | ๐ฎ๐ฑ Israel |